BPC-157 / TB-500
Dual Peptide Blend · Wolverine
Also referenced as: BPC-157 / TB-500 Blend · Dual Peptide Research Blend · BPC + TB Stack
≥99% Purity Guaranteed
Full Panel COA
UPS 2-Day Air Shipping
Shipment InsuredShipment Insurance Included
Lab Results
| Test | Result | Status |
|---|---|---|
| Purity | Pending | Pending |
| Quantitation (Avg) | Pending | Pending |
| Heavy Metals (ICP-MS) | Pending | Pending |
| Endotoxin (USP <85>) | Pending | Pending |
| Sterility (PCR) | Pending | Pending |
| Multi Vial Tested | Pending | Pending |
Made in cGMP- and ISO-certified facilities vetted by our established North American supply partner. Virtus tracks the factory batch number on every lot and catalogues it against independent lab testing, with a final Certificate of Analysis from ILS Laboratories. We pay more to source this way because we hold the highest standard for the product and for you.
Curated research on BPC-157 / TB-500
Seiwerth S (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing Front Pharmacol.
PMID: 34267654 →Goldstein AL (2005). Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues Trends Mol Med.
PMID: 16099219 →Sikiric P (2020). Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response Gut Liver.
PMID: 31158953 →Bock-Marquette I (2004). Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair Nature.
PMID: 15580368 →
About BPC-157 / TB-500
A precision research blend of BPC-157 (10mg) and TB-500 (10mg), two of the most studied synthetic peptides in current preclinical literature. Investigated in laboratory models examining cellular signaling interactions, actin-binding mechanisms, and extracellular matrix pathway activity.
In controlled research models, BPC-157 has been studied for modulation of nitric oxide signaling pathways and cytokine expression in cellular environments. TB-500 research has examined upregulation of actin-binding proteins and neovascularization mechanisms at the cellular level. Combined formulation enables researchers to study potential synergistic interactions within controlled in-vitro environments.
Also Referenced As
BPC-157 / TB-500 Blend · Dual Peptide Research Blend · BPC + TB Stack
Specifications
- Scientific Name
- BPC-157 + TB-500: Dual Peptide Research Blend
- CAS Number
- 137525-51-0 / 77591-33-4
- Molecular Formula
- BPC-157 C₆₂H₉₈N₁₆O₂₂ · TB-500 C₂₁₂H₃₅₀N₅₆O₇₈S
- Molecular Weight
- BPC-157 1419.54 g/mol · TB-500 4963.49 g/mol
- Physical Form
- Lyophilized powder
- Purity
- 99%+
- Batch Number
- 46239
- Storage
- −20°C, protected from light
Storage & Handling
Lyophilized peptides remain stable for 12–24 months when stored properly. Follow standard laboratory protocols for handling.
Storage
Store lyophilized peptide at −20°C in a standard laboratory freezer, protected from light, moisture, and heat. Avoid repeated freeze-thaw cycles.
Shelf Life
Lyophilized form remains stable for 12–24 months at −20°C in the original sealed vial. Always reference the batch-specific COA for verified shelf-life data.
Mechanism & Research Background
Wolverine combines two of the most heavily studied synthetic peptides in current preclinical research literature, BPC-157 and TB-500, at 10mg each in a single 20mg lyophilized vial. The pairing reflects a research design grounded in the distinct, complementary cellular pathways each peptide engages: BPC-157 (Body Protection Compound 157) operates through pentadecapeptide signaling and angiogenesis-related pathway modulation, while TB-500 (a synthetic fragment of thymosin β4) acts through actin-sequestering and cell-migration mechanisms. Both peptides have independent corpora of peer-reviewed research on PubMed; the blend is formulated for researchers investigating potential combined or sequential exposure within controlled in-vitro environments.
In pathway research, BPC-157 is a synthetic 15-amino acid peptide derived from a sequence found in human gastric juice. Published preclinical work has examined its activity at the cellular level across nitric oxide signaling, cytokine modulation, fibroblast biology, and angiogenesis pathway markers (Seiwerth et al., Front Pharmacol, 2021; Sikiric et al., Gut Liver, 2020; Gwyer et al., Cell Tissue Res, 2019). TB-500 is the synthetic active fragment of thymosin β4, an actin-sequestering protein with characterized effects on cell migration, neovascularization markers, and extracellular matrix interactions in preclinical research models (Goldstein et al., Trends Mol Med, 2005).
The blend formulation enables researchers to examine combined exposure to both peptides without the experimental variability of two separately reconstituted preparations. Each batch is independently tested at ILS Laboratories: purity and quantitation by HPLC, heavy metals by ICP-MS (lead, arsenic, cadmium, chromium, and mercury), bacterial endotoxin by USP <85>, and sterility by PCR, with quantitation and identity confirmed across five vials per batch for conformity (a full QC panel on three, plus two additional vials); the Certificate of Analysis reflects the combined-peptide composition. Products supplied by Virtus Peptides are intended exclusively for in-vitro laboratory research and are not for human or animal use.
Frequently Researched Questions
What is Wolverine?
Wolverine is a precision research blend combining BPC-157 (10mg) and TB-500 (10mg) in a single 20mg lyophilized vial. The blend is formulated for researchers studying potential combined effects of pentadecapeptide signaling (BPC-157) and actin-sequestering protein activity (TB-500) in controlled in-vitro environments.
How much BPC-157 and TB-500 is in each vial?
Each Wolverine vial contains 10mg of BPC-157 and 10mg of TB-500, lyophilized together in a 20mg combined preparation. Both peptides are independently tested for purity prior to blending.
Why blend BPC-157 and TB-500 together?
The two peptides have non-overlapping mechanisms in published research literature: BPC-157 has been studied in angiogenesis pathway and cytokine signaling research, while TB-500 contributes characterized actin-sequestering and cell-migration activity. The blend allows researchers to examine potential synergistic interactions in a controlled in-vitro setting without the variability introduced by two separately reconstituted preparations.
What testing does Virtus run on Wolverine?
Every batch of Wolverine is independently tested by ILS Laboratories (ISO/IEC 17025 accredited) across the full QC panel: purity and quantitation by HPLC, heavy metals by ICP-MS (lead, arsenic, cadmium, chromium, and mercury), bacterial endotoxin by USP <85>, and sterility by PCR. Quantitation and identity are confirmed across five vials per batch for conformity (a full QC panel on three, plus two additional vials). The Certificate of Analysis reflects the combined-peptide composition.
How should Wolverine be stored?
Lyophilized Wolverine should be stored at −20°C, protected from light, in the original sealed vial. Repeated freeze-thaw cycles should be avoided. When stored correctly, lyophilized peptides typically maintain stability for 12–24 months.
Where can I find published research on BPC-157 and TB-500?
PubMed indexes peer-reviewed research on each peptide independently. For BPC-157 search "BPC-157" or "gastric pentadecapeptide" for landmark papers by Seiwerth, Sikiric, and colleagues. For TB-500 search "TB-500" or "Thymosin beta-4 fragment" for foundational work by Goldstein and others on actin-sequestering activity.
